Pages that link to "Q418050"
Jump to navigation
Jump to search
The following pages link to sertindole (Q418050):
Displaying 38 items.
- 5-hydroxytryptamine receptor 1B (Q288797) (← links)
- Dopamine receptor D4 (Q308856) (← links)
- Histamine receptor H1 (Q309513) (← links)
- 5-hydroxytryptamine receptor 2A (Q1949517) (← links)
- dopamine receptor D2 (Q2034004) (← links)
- 5-hydroxytryptamine receptor 2C (Q21108118) (← links)
- Dopamine receptor D3 (Q21110872) (← links)
- 5-hydroxytryptamine receptor 1A (Q21115043) (← links)
- 5-hydroxytryptamine receptor 1D (Q21115046) (← links)
- 5-hydroxytryptamine receptor 1E (Q21115051) (← links)
- 5-hydroxytryptamine receptor 1F (Q21115052) (← links)
- A review of the efficacy, tolerability and safety of sertindole in clinical trials (Q35906819) (← links)
- Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic (Q36179715) (← links)
- Sertindole : a review of its use in schizophrenia (Q36418019) (← links)
- The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. (Q36897871) (← links)
- Sertindole for the treatment of schizophrenia. (Q37809874) (← links)
- A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia (Q46827385) (← links)
- Sertindole: dilemmas for its use in clinical practice (Q48512500) (← links)
- Sertindole in Asian Patients With Schizophrenia (Q61981197) (← links)
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) (Q63318336) (← links)
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (Q63844840) (← links)
- The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia (Q64350286) (← links)
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients (Q64598214) (← links)
- Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA) (Q64679089) (← links)
- Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia (Q64714470) (← links)
- Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia (Q64715294) (← links)
- Exploratory Cognition Study of Sertindole in Patients With Schizophrenia (Q64715301) (← links)
- Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia (Q64719949) (← links)
- The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients (Q64721668) (← links)
- The Effect of Sertindole on Sensory Gating and Cognition in Healthy Volunteers (Q64724067) (← links)
- Pharmacovigilance in Gerontopsychiatric Patients (Q65347289) (← links)
- Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone (Q65382028) (← links)
- Augmenting Clozapine With Sertindole - SERCLOZ (Q65388840) (← links)
- Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use (Q65536705) (← links)
- Sertindole: pharmacological and clinical profile and role in the treatment of schizophrenia (Q81290971) (← links)
- User:DeltaBot/fixClaims/maintenance/P715format (← links | edit)
- Wikidata:Database reports/Constraint violations/P2175 (← links | edit)
- Wikidata:Database reports/Constraint violations/P2275 (← links | edit)